FAAH/MAGL-IN-5

• CAT Number: R064847
• CAS Number: 1010096-65-7
• Molecular Formula: C17H17N5O
• Molecular Weight: 307.35
• Purity: ≥95%
• Synonyms: N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-2-carboxamide
• InChI: InChI=1S/C17H17N5O/c1-21(2)17(23)22-19-16(18-20-22)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3
• InChIKey: VBVLSXPOMAONNK-UHFFFAOYSA-N
• SMILES: CN(C)C(=O)N1N=C(N=N1)CC2=CC=C(C=C2)C3=CC=CC=C3

FAAH/MAGL-IN-5(CAT: R064847) is a dual inhibitor targeting fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), two key enzymes responsible for the degradation of endocannabinoids such as anandamide and 2-AG. By simultaneously blocking FAAH and MAGL, this compound elevates endocannabinoid levels, enhancing cannabinoid receptor signaling involved in pain modulation, neuroprotection, inflammation, and mood regulation. FAAH/MAGL-IN-5 is widely used in neuroscience and inflammation research to study the endocannabinoid system and develop potential therapeutics for chronic pain, anxiety, and neurodegenerative diseases. Its balanced potency and selectivity make it ideal for preclinical exploration of dual-target endocannabinoid modulation.